Skip to main content
Log in

Association Between Dose and Duration of Cisplatin Exposure with Cytotoxicity Effect on Nasopharyngeal Carcinoma Stem Cell

  • Original Article
  • Published:
Indian Journal of Otolaryngology and Head & Neck Surgery Aims and scope Submit manuscript

Abstract

Nasopharyngeal carcinoma (NPC) is ranked 6th of malignant tumors in Indonesia. To analyze the correlation of dose and duration of cisplatin exposure with cytotoxic effects on nasopharyngeal carcinoma stem cells. The biopsy NPC tissue was cultured and processed to obtain NPC stem cells to be treated with cisplatin different doses and durations (24 and 48 h). The number of dead cells after exposure will be calculated using a hemocytometer. Death stem cell density of NPC at exposure of 2 μg/ml cisplatin dose was 81.37%, while the smallest death cell density a dose of 0.05 μg/ml after a 72-h observation was 21.3%. The coefficient correlation 0.827 and value p = 0.000 (p < 0.05). The analysis of the correlation between cisplatin exposure duration and death cell was also significant with the correlation coefficient − 0.357 and the value p = 0.001 (p < 0.05). There was a correlation between the increased dose of cisplatin with the cytotoxicity effects on NPC stem cell.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Adham M, Kurniawan AN, Muhtadi AI, Roezin A, Hermani B, Gondhowiardjo S et al (2012) Nasopharyngeal carcinoma in Indonesia: epidemiology, incidence, signs, and symptoms at presentation. Chin J Cancer 31(4):185–196

    Article  CAS  Google Scholar 

  2. Roezin A, Syafril A (2006) Buku ajar Ilmu Penyakit Telinga Hidung Tenggorok. Edisi kelima. Jakarta, FKUI

    Google Scholar 

  3. Longo-Sorbello G, Saydam G, Banerjee D, Bertino J (2006) Cytotoxicity and cell growth assays. In: Celis J, Charter N, Simons K, Small J, Hunter T, Shotton D (eds) Cell biology, four-volume set: a laboratory handbook, vol 1, 3rd edn. Academic Press, Amsterdam, pp 315–324

  4. Jamieson ER, Lippard SJ (1999) Structure, recognition, and processing of cisplatin-DNA adducts. Chem Rev 99(9):2467–2498

    Article  CAS  Google Scholar 

  5. Cepeda V, Fuertes MA, Castilla J, Alonso C, Quevedo C, Perez JM (2007) Biochemical mechanisms of cisplatin cytotoxicity. Anticancer Agents Med Chem 7(1):3–18

    Article  CAS  Google Scholar 

  6. Chan AT, Teo PM, Leung TW, Leung SF, Lee WY, Yeo W et al (1995) A prospective randomized study of chemotherapy adjunctive to definitive radiotherapy in advanced nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys 33(3):569–577

    Article  CAS  Google Scholar 

  7. Ma J, Mai HQ, Hong MH, Min HQ, Mao ZD, Cui NJ et al (2001) Results of a prospective randomized trial comparing neoadjuvant chemotherapy plus radiotherapy with radiotherapy alone in patients with locoregionally advanced nasopharyngeal carcinoma. J Clin Oncol Off J Am Soc Clin Oncol 19(5):1350–1357

    Article  CAS  Google Scholar 

  8. Monroe MM, Anderson EC, Clayburgh DR, Wong MH (2011) Cancer stem cells in head and neck squamous cell carcinoma. J Oncol 2011:762780

    Article  Google Scholar 

  9. Shafee N, Smith CR, Wei S, Kim Y, Mills GB, Hortobagyi GN et al (2008) Cancer stem cells contribute to cisplatin resistance in Brca1/p53-mediated mouse mammary tumors. Can Res 68(9):3243–3250

    Article  CAS  Google Scholar 

  10. Troger V, Fischel JL, Formento P, Gioanni J, Milano G (1992) Effects of prolonged exposure to cisplatin on cytotoxicity and intracellular drug concentration. Eur J Cancer 28(1):82–86

    Article  CAS  Google Scholar 

  11. Pisano C, Pratesi G, Laccabue D, Zunino F, Lo Giudice P, Bellucci A et al (2003) Paclitaxel and cisplatin-induced neurotoxicity: a protective role of acetyl-l-carnitine. Clin Cancer Res Off J Am Assoc Cancer Res 9(15):5756–5767

    CAS  Google Scholar 

  12. Wu YJ, Muldoon LL, Neuwelt EA (2005) The chemoprotective agent N-acetylcysteine blocks cisplatin-induced apoptosis through caspase signaling pathway. J Pharmacol Exp Ther 312(2):424–431

    Article  CAS  Google Scholar 

  13. Hong JY, Kim GH, Kim JW, Kwon SS, Sato EF, Cho KH et al (2012) Computational modeling of apoptotic signaling pathways induced by cisplatin. BMC Syst Biol 6:122

    Article  CAS  Google Scholar 

  14. Hanigan MH, Deng M, Zhang L, Taylor PT Jr, Lapus MG (2005) Stress response inhibits the nephrotoxicity of cisplatin. Am J Physiol Renal Physiol 288(1):F125–F132

    Article  CAS  Google Scholar 

  15. Saris CP, van de Vaart PJ, Rietbroek RC, Blommaert FA (1996) In vitro formation of DNA adducts by cisplatin, lobaplatin and oxaliplatin in calf thymus DNA in solution and in cultured human cells. Carcinogenesis 17(12):2763–2769

    Article  CAS  Google Scholar 

  16. Fanning J, Biddle WC, Goldrosen M, Crickard K, Crickard U, Piver MS et al (1990) Comparison of cisplatin and carboplatin cytotoxicity in human ovarian cancer cell lines using the MTT assay. Gynecol Oncol 39(2):119–122

    Article  CAS  Google Scholar 

  17. Leist M, Nicotera P (1997) The shape of death cell. Biochem Biophys Res Commun 236(1):1–9

    Article  CAS  Google Scholar 

  18. Park MS, De Leon M, Devarajan P (2002) Cisplatin induces apoptosis in LLC-PK1 cells via activation of mitochondrial pathways. J Am Soc Nephrol JASN 13(4):858–865

    CAS  PubMed  Google Scholar 

  19. Martelli L, Ragazzi E, Di Mario F, Basato M, Martelli M (2009) Cisplatin and oxaliplatin cytotoxic effects in sensitive and cisplatin-resistant human cervical tumor cells: time and mode of application dependency. Anticancer Res 29(10):3931–3937

    CAS  PubMed  Google Scholar 

  20. Liao SK, Perng YP, Shen YC, Chung PJ, Chang YS, Wang CH (1998) Chromosomal abnormalities of a new nasopharyngeal carcinoma cell line (NPC-BM1) derived from a bone marrow metastatic lesion. Cancer Genet Cytogenet 103(1):52–58

    Article  CAS  Google Scholar 

  21. Nilsson JR (2008) Cytotoxic effect of cisplatin on Tetrahymena. J Cell Sci 90:707–716

    Google Scholar 

  22. Masters RW (2000) Animal cell culture, trypan blue assay sop, 3rd edn. JB Lippincott, Philadelphia

    Google Scholar 

  23. Wang X, Wong SC, Pan J, Tsao SW, Fung KH, Kwong DL et al (1998) Evidence of cisplatin-induced senescent-like growth arrest in nasopharyngeal carcinoma cells. Can Res 58(22):5019–5022

    CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Widodo Ario Kentjono.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Wardhani, L.K., Kentjono, W.A. & Romdhoni, A.C. Association Between Dose and Duration of Cisplatin Exposure with Cytotoxicity Effect on Nasopharyngeal Carcinoma Stem Cell. Indian J Otolaryngol Head Neck Surg 71 (Suppl 1), 373–377 (2019). https://doi.org/10.1007/s12070-018-1317-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12070-018-1317-4

Keywords

Navigation